The α/β T cell receptor (TCR) recognizes peptide fragments bound in the groove of major histocompatibility complex (MHC) molecules. We modified the TCR α chain from a mouse T cell hybridoma and tested its ability to reconstitute TCR expression and function in an α chain–deficient variant of the hybridoma. The modified α chain differed from wild type only in its leader peptide and mature NH2-terminal amino acid. Reconstituted cell surface TCR complexes reacted normally with anti-TCR and anti-CD3 antibodies. Although cross-linking of this TCR with an antibody to the TCR idiotype elicited vigorous T cell hybridoma activation, stimulation with its natural MHC + peptide ligand did not. We demonstrated that this phenotype could be reproduced simply by substituting the glutamic acid (E) at the mature NH2 terminus of the wild type TCR α chain with aspartic acid (D). The substitution also dramatically reduced the affinity of soluble α/β-TCR heterodimers for soluble MHC + peptide molecules in a cell-free system, suggesting that it did not exert its effect simply by disrupting TCR interactions with accessory molecules on the hybridoma. These results demonstrate for the first time that amino acids which are not in the canonical TCR complementarity determining regions can be critical in determining how the TCR engages MHC + peptide.
Skip Nav Destination
Article navigation
2 June 1997
Article|
June 02 1997
Influence of the NH2-terminal Amino Acid of the T Cell Receptor α Chain on Major Histocompatibility Complex (MHC) Class II + Peptide Recognition
Jeffrey L. Seibel,
Jeffrey L. Seibel
From the *Howard Hughes Medical Institute, ‡Department of Medicine, National Jewish Medical and Research Center, and §Department of Immunology, ‖Department of Biochemistry, Biophysics and Genetics, and ¶Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
Search for other works by this author on:
Nancy Wilson,
Nancy Wilson
From the *Howard Hughes Medical Institute, ‡Department of Medicine, National Jewish Medical and Research Center, and §Department of Immunology, ‖Department of Biochemistry, Biophysics and Genetics, and ¶Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
Search for other works by this author on:
Haruo Kozono,
Haruo Kozono
From the *Howard Hughes Medical Institute, ‡Department of Medicine, National Jewish Medical and Research Center, and §Department of Immunology, ‖Department of Biochemistry, Biophysics and Genetics, and ¶Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
Search for other works by this author on:
Philippa Marrack,
Philippa Marrack
From the *Howard Hughes Medical Institute, ‡Department of Medicine, National Jewish Medical and Research Center, and §Department of Immunology, ‖Department of Biochemistry, Biophysics and Genetics, and ¶Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
Search for other works by this author on:
John W. Kappler
John W. Kappler
From the *Howard Hughes Medical Institute, ‡Department of Medicine, National Jewish Medical and Research Center, and §Department of Immunology, ‖Department of Biochemistry, Biophysics and Genetics, and ¶Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
Search for other works by this author on:
Jeffrey L. Seibel
From the *Howard Hughes Medical Institute, ‡Department of Medicine, National Jewish Medical and Research Center, and §Department of Immunology, ‖Department of Biochemistry, Biophysics and Genetics, and ¶Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
Nancy Wilson
From the *Howard Hughes Medical Institute, ‡Department of Medicine, National Jewish Medical and Research Center, and §Department of Immunology, ‖Department of Biochemistry, Biophysics and Genetics, and ¶Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
Haruo Kozono
From the *Howard Hughes Medical Institute, ‡Department of Medicine, National Jewish Medical and Research Center, and §Department of Immunology, ‖Department of Biochemistry, Biophysics and Genetics, and ¶Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
Philippa Marrack
From the *Howard Hughes Medical Institute, ‡Department of Medicine, National Jewish Medical and Research Center, and §Department of Immunology, ‖Department of Biochemistry, Biophysics and Genetics, and ¶Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
John W. Kappler
From the *Howard Hughes Medical Institute, ‡Department of Medicine, National Jewish Medical and Research Center, and §Department of Immunology, ‖Department of Biochemistry, Biophysics and Genetics, and ¶Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
Address correspondence to Dr. Philippa Marrack, National Jewish Center for Immunology and Respiratory Medicine, Goodman Bldg., 5th Floor, 1400 Jackson St., Denver, CO 80206.
Received:
February 10 1997
Revision Received:
March 31 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 185 (11): 1919–1927.
Article history
Received:
February 10 1997
Revision Received:
March 31 1997
Citation
Jeffrey L. Seibel, Nancy Wilson, Haruo Kozono, Philippa Marrack, John W. Kappler; Influence of the NH2-terminal Amino Acid of the T Cell Receptor α Chain on Major Histocompatibility Complex (MHC) Class II + Peptide Recognition. J Exp Med 2 June 1997; 185 (11): 1919–1927. doi: https://doi.org/10.1084/jem.185.11.1919
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement